MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Boston Sci Making $210 Million Acquisition

Buying EndoChoice Holdings will allow Boston Sci to expand its successful endoscopy business.

Chris Newmarker

EndoChoice FUSE System
EndoChoice's Full Spectrum Endoscopy (FUSE) colonoscope (Image courtesy of EndoChoice)

Boston Scientific said Tuesday that it will launch a tender offer of $8 per share--a roughly $210 million purchase--EndoChoice Holdings.

Based near Atlanta, EndoChoice is a $75 million a year business with products including endoscopic imaging systems, devices, and infection control products. It will join Boston Sci's existing endoscopy business.

"The addition of EndoChoice products and services to our portfolio supports our strategy to provide  comprehensive solutions to gastroenterology caregivers and the patients they serve," Art Butcher, senior vice president and president of Boston Scientific's endoscopy business, said in a news release.

"We expect the acquisition to expand our leadership into new categories in the endoscopy market, and to drive strong, continued growth of our endoscopy business," Butcher said.

Endoscopy has been a solid performer for Boston Scientific's business. The endoscopy business brought in $755 million in sales during the first half of 2016, an 11% increase from a year before. Overall Boston Sci sales were up 13% year-over-year, to $4.09 billion, during the same period.

The EndoChoice purchase is expected to close during the final three months of 2016, pending customary closing conditions. Boston Sci says it plans to "evaluate strategic options," corporate speak for seeking a potential sale, of EndoChoice's Full Spectrum Endoscopy (FUSE) colonoscope, which enables doctors to better visualize colonoscopies.

Find out about the latest medical device innovations at BIOMEDevice San Jose, December 7-8, 2016.

Chris Newmarker is senior editor of Qmed. Follow him on Twitter at @newmarker.

Like what you're reading? Subscribe to our daily e-newsletter.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish